These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10036720)
21. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice. Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921 [TBL] [Abstract][Full Text] [Related]
23. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. McKenney D; Pouliot KL; Wang Y; Murthy V; Ulrich M; Döring G; Lee JC; Goldmann DA; Pier GB Science; 1999 May; 284(5419):1523-7. PubMed ID: 10348739 [TBL] [Abstract][Full Text] [Related]
25. Challenges for a universal Staphylococcus aureus vaccine. Proctor RA Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924 [TBL] [Abstract][Full Text] [Related]
26. Staphylococcal vaccine one step closer to reality. Habeck M Lancet Infect Dis; 2002 Apr; 2(4):201. PubMed ID: 11937412 [No Abstract] [Full Text] [Related]
27. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. Harro JM; Peters BM; O'May GA; Archer N; Kerns P; Prabhakara R; Shirtliff ME FEMS Immunol Med Microbiol; 2010 Aug; 59(3):306-23. PubMed ID: 20602638 [TBL] [Abstract][Full Text] [Related]
28. CD40 triggering induces strong cytotoxic T lymphocyte responses to heat-killed Staphylococcus aureus immunization in mice: a new vaccine strategy for staphylococcal mastitis. Wallemacq H; Bedoret D; Pujol J; Desmet C; Drion PV; Farnir F; Mainil J; Lekeux P; Bureau F; Fiévez L Vaccine; 2012 Mar; 30(12):2116-24. PubMed ID: 22285272 [TBL] [Abstract][Full Text] [Related]
29. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage. Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513 [TBL] [Abstract][Full Text] [Related]
30. Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. Alonzo F; Torres VJ PLoS Pathog; 2013 Feb; 9(2):e1003143. PubMed ID: 23436994 [No Abstract] [Full Text] [Related]
31. Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Projan SJ; Nesin M; Dunman PM Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507 [TBL] [Abstract][Full Text] [Related]
32. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model. Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117 [TBL] [Abstract][Full Text] [Related]
33. Immunization routes in cattle impact the levels and neutralizing capacity of antibodies induced against S. aureus immune evasion proteins. Boerhout E; Vrieling M; Benedictus L; Daemen I; Ravesloot L; Rutten V; Nuijten P; van Strijp J; Koets A; Eisenberg S Vet Res; 2015 Sep; 46():115. PubMed ID: 26411347 [TBL] [Abstract][Full Text] [Related]
34. Symposium review: Features of Staphylococcus aureus mastitis pathogenesis that guide vaccine development strategies. Côté-Gravel J; Malouin F J Dairy Sci; 2019 May; 102(5):4727-4740. PubMed ID: 30580940 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567 [TBL] [Abstract][Full Text] [Related]
36. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
37. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Balaban N; Goldkorn T; Nhan RT; Dang LB; Scott S; Ridgley RM; Rasooly A; Wright SC; Larrick JW; Rasooly R; Carlson JR Science; 1998 Apr; 280(5362):438-40. PubMed ID: 9545222 [TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Dayan GH; Mohamed N; Scully IL; Cooper D; Begier E; Eiden J; Jansen KU; Gurtman A; Anderson AS Expert Rev Vaccines; 2016 Nov; 15(11):1373-1392. PubMed ID: 27118628 [TBL] [Abstract][Full Text] [Related]
39. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus. Sutra L; Poutrel B J Med Microbiol; 1994 Feb; 40(2):79-89. PubMed ID: 8107066 [TBL] [Abstract][Full Text] [Related]
40. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide. Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]